Medication treatment for depression in children and adolescents

CNS Spectrums

Volumn 8, Issue 4, 2003, Pages 283-287

  Ryan, Neal D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADOLESCENT; CHILD; DEPRESSION; DRUG EFFICACY; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; REVIEW; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MAJOR DEPRESSION; METHODOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0037853342     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900018496     Document Type: Review

References (34)

1. Puig-Antich J, Blau S, Marx N, Greenhill LL, Chambers W. Prepubertal major depressive disorder: a pilot study. J Am Acad Child Psychiatry. 1978;17:695-707.
2. Ryan ND, Puig-Antich J, Ambrosini P, et al. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry. 1987;44:854-861.
3. Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R. Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry. 1984;41:229-237.
4. Kovacs M, Feinberg TL, Crouse-Novak M, Paulauskas SL, Pollock M, Finkelstein R. Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry. 1984;41:643-649.
5. Puig-Antich J, Goetz D, Davies M, et al. A controlled family history study of prepubertal major depressive disorder. Arch Gen Psychiatry. 1989;46:406-418.
6. Williamson DE, Ryan ND, Birmaher B, et al. A case-control family history study of depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:1596-1607.
7. Ryan ND. Psychoneuroendocrinology of children and adolescents. Psychiatr Clin North Am. 1998;21:435-441.
8. Harrington R, Whittaker J, Shoebridge P, Campbell F. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. Br Med J. 1998;316:1559-1563.
9. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry. 2001;178:234-241.
10. Petti TA, Law W 3rd. Imipramine treatment of depressed children: a double-blind pilot study. J Clin Psychopharmacol. 1982;2:107-110.
11. Kashani JH, Shekim WO, Reid JC. Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study. J Am Acad Child Psychiatry. 1984;23:348-351.
12. Preskorn SH, Weller EB, Hughes CW, Weller RA, Bolte K. Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Psychopharmacol Bull. 1987;23:128-133.
13. Puig-Antich J, Perel JM, Lupatkin W, et al. Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry. 1987;44:81-89.
14. Geller B, Cooper TB, McCombs HG, Graham D, Wells J. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. Psychopharmacol Bull. 1989;25:101-108.
15. Hughes CW, Preskorn SH, Weller E, Weller R, Hassanein R, Tucker S. The effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacol Bull. 1990;26:235-238.
16. Kramer AD, Feiguine RJ. Clinical effects of amitriptyline in adolescent depression. A pilot study. J Am Acad Child Psychiatry. 1981;20:636-644.
17. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull. 1990;26:85-90.
18. Klein RG, Koplewicz HS, Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry. 1992;31:21-28.
19. Kutcher S, Boulos C, Ward B, et al. Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 1994;33:686-694.
20. Kye CH, Waterman GS, Ryan ND, et al. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry. 1996;35:1139-1144.
21. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40:762-772.
22. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry. 1996;35:1575-1583.
23. Simeon JG, Dinicola VF, Ferguson HB, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:791-795.
24. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Carson SW, Sethuraman G. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry. 1997;154:668-673.
25. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037.
26. Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 10-14, 2000; San Juan, Puerto Rico.
27. Wagner KD, Robb AS, Findling R, Tiseo PJ. Citalopram is effective in the treatment of major depressive disorder in children and adolescents: results of a placebo-controlled trial. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 2001; Waikaloa, HI.
28. Donnelly CL, Winokur A, Wohlberg CJ. Efficacy and safety of sertraline in the treatment of pediatric major depressive disorder. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 2001; Waikaloa, HI.
29. Ryan ND, Puig-Antich J, Rabinovich H, et al. MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1988;27:755-758.
30. Ryan ND, Meyer V, Dachille S, Mazzie D, Puig-Antich J. Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1988;27:371-376.
31. Strober M, Freeman R, Rigali J, Schmidt S, Diamond R. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry. 1992;31:16-20.
32. Emslie GJ, Mayes TL. Mood disorders in children and adolescents: psychopharmacological treatment. Biol Psychiatry. 2001;49:1082-1090.
33. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773-1778.
34. Gamble VN. The Tuskegee Syphilis Study and women's health. J Am Med Womens Assoc. 1997;52:195-196.